Loading clinical trials...
Loading clinical trials...
Cala TWO Device: Clinical Efficacy and Effects on Regional Brain Metabolism in Essential Tremor Subjects Scheduled to Undergo Deep Brain Stimulation Surgery
Conditions
Interventions
Cala TWO stimulator
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
February 11, 2019
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
January 30, 2026
NCT07428447
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions